查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1674166

核黃素市場：依形式、來源、應用、地區

Riboflavin Market, By Form, By Source, By Application, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 162 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025年全球核黃素市場規模估計為 4.934億美元，預計到2032年將達到 7.876億美元，2025-2032年的年複合成長率為 6.9%。

報告範圍 報告詳細資訊
基準年 2024 2025年的市場規模 4.934億美元
歷史資料 從2020年到2024年 預測期 2025-2032年
預測期：2025-2032年年複合成長率： 6.90％ 2032年價值預測 7.876億美元
圖表.2025年核黃素各地區市場佔有率（%）
核黃素市場-IMG1

核黃素又稱維生素B2，是人體生長發育所必需的營養素。它作為黃素單核苷酸和黃素腺嘌呤二核苷酸的前體，在各種代謝過程中發揮重要作用。核黃素是一種水溶性維生素，必須從飲食中攝取。核黃素天然存在於多種食物中，包括牛奶、雞蛋、肉類、綠葉蔬菜、蘑菇和豆類。核黃素缺乏會導致嘴角乾裂、口腔發炎、喉嚨痛、皮膚搔癢、脂漏性皮膚炎等健康問題。由於人們健康意識的增強和對膳食補充劑的需求不斷增加，全球核黃素在不久的將來可能會出現成長。

市場動態

全球核黃素市場的成長受到消費者對膳食補充劑的偏好上升、健康意識增強、核黃素缺乏症病例增加以及食品和飲料行業擴張等因素的推動。然而，從食物中天然提取核黃素和合成生產的高成本可能會阻礙市場成長。核黃素作為藥品、化妝品和飼料添加劑的新應用可以為市場擴張開闢新的途徑。然而，由於許多日常食物中都含有核黃素，市場面臨一定的限制。嚴格的膳食補充劑監管標準可能會阻礙市場成長。由於從非肉類飲食中攝取核黃素比較困難，因此素食和素食飲食的日益普及可能代表著成長機會。產品創新帶來配方的改進，提供了另一個成長前景。

本研究的主要特點

本報告對全球核黃素市場進行了詳細分析，以2024年為基準年，並提供了預測期（2025-2032）的市場規模（百萬美元）和年複合成長率（CAGR%）。

揭示各個領域的潛在商機，並解釋了該市場的有吸引力的投資提案矩陣。

提供有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。

根據公司亮點、產品系列、關鍵亮點、業績和策略等參數，介紹了全球核黃素市場的主要企業概況。

本研究包括的主要企業包括BASF SE、Koninklijke DSM NV、Shanghai Acebright Pharmaceuticals Group Co.Ltd.、Xinfa Pharmaceutical Co.Ltd.、Hubei Guangji Pharmaceutical Co.Ltd.、NB Group Co.Ltd.、Hegno、Legend Industries、Hebei Shengxue dacheng Pharmaceutical Co.Ltd.、Duchefa Biochemie、Harman Finichem Ltd.。

本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。

全球核黃素市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。

相關人員可以透過用於分析全球核黃素市場的各種策略矩陣來促進決策。

目錄

第1章 調查目的與前提條件

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要

第3章 市場動態、法規與趨勢分析

  • 市場動態
    • 促進因素
    • 限制因素
    • PEST分析
    • 波特五力分析
    • 市場機會
    • 監管情景
    • 主要進展
    • 產業趨勢

第4章 全球核黃素市場-冠狀病毒（COVID-19）大流行的影響

  • 影響全球核黃素市場的因素-COVID-19
  • 影響分析

第5章 全球核黃素市場，依形式，2020-2032

  • 粉末
  • 液體

第6章 全球核黃素市場，依來源，2020-2032年

  • 植物
  • 動物

第7章 全球核黃素市場，依應用，2020-2032年

  • 飲食
  • 營養補充品
  • 製藥
  • 動物飼料
  • 個人護理
  • 其他

第8章 2020-2032年全球核黃素市場，依地區

  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第9章 競爭格局

  • 熱圖分析
  • 市場佔有率分析（3x3矩陣）
  • 公司簡介
    • BASF SE
    • Koninklijke DSM NV
    • Shanghai Acebright Pharmaceuticals Group Co. Ltd.
    • Xinfa Pharmaceutical Co. Ltd
    • Hubei Guangji Pharmaceutical Co. Ltd
    • NB Group Co. Ltd
    • Hegno
    • Legend Industries
    • Hebei Shengxue dacheng Pharmaceutical Co. Ltd
    • Duchefa Biochemie
    • Harman Finichem Ltd

第10章 分析師建議

  • 機會
  • 分析師觀點
  • Coherent Opportunity Map

第11章 章節

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI5140

Global Riboflavin Market is estimated to be valued at USD 493.4 Mn in 2025 and is expected to reach USD 787.6 Mn by 2032, growing at a compound annual growth rate (CAGR) of 6.9% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 493.4 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 6.90% 2032 Value Projection: USD 787.6 Mn
Figure. Riboflavin Market Share (%), By Region 2025
Riboflavin Market - IMG1

Riboflavin, also known as vitamin B2, is an essential nutrient required by the human body for growth and development. It plays a vital role in various metabolic processes through its involvement as a precursor for flavin mononucleotide and flavin adenine dinucleotide. As a water-soluble vitamin, riboflavin needs to be supplemented through diet. It is naturally present in a variety of foods including milk, eggs, meat, leafy green vegetables, mushrooms, and legumes. Deficiency of riboflavin can lead to health issues like cracks at the corners of the mouth, inflammation of the mouth, sore throat, itchy skin, and seborrheic dermatitis. Due to growing health awareness and increasing demand for nutritional supplements, global riboflavin can witness growth in the near future.

Market Dynamics-

Global riboflavin market growth is driven by factors such as increasing consumer preference for nutritional supplements, growing health consciousness, rising cases of riboflavin deficiencies, and expanding food & beverage industry. However, high costs associated with natural extraction of riboflavin from foods and synthetic production can hamper the market growth. Novel applications of riboflavin as an additive in pharmaceuticals, cosmetics and animal feed can present new avenues for market expansion. However, the market faces certain restraints due to presence of riboflavin in many routine foods. Strict regulatory norms governing dietary supplements can hamper the market growth. Increasing adoption of vegan and vegetarian diets as riboflavin intake can be challenging through a non-meat diet can offer growth opportunities. Product innovation leading to enhanced formulations presents another favorable growth prospect.

Key Features of the Study-

This report provides in-depth analysis of the global riboflavin market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global riboflavin market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include BASF SE, Koninklijke DSM NV, Shanghai Acebright Pharmaceuticals Group Co. Ltd., Xinfa Pharmaceutical Co. Ltd, Hubei Guangji Pharmaceutical Co. Ltd, NB Group Co. Ltd, Hegno, Legend Industries, Hebei Shengxue dacheng Pharmaceutical Co. Ltd, Duchefa Biochemie, and Harman Finichem Ltd

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global riboflavin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global riboflavin market

Market Segmentation

  • Form Insights (Revenue, USD, 2020 - 2032)
    • Powder
    • Liquid
  • Source Insights (Revenue, USD, 2020 - 2032)
    • Plant
    • Animal
  • Application Insights (Revenue, USD, 2020 - 2032)
    • Food and Beverages
    • Dietary Supplements
    • Pharmaceutical
    • Animal Feed
    • Personal Care
    • Others
  • Regional Insights (Revenue, USD, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • BASF SE
    • Koninklijke DSM NV
    • Shanghai Acebright Pharmaceuticals Group Co. Ltd.
    • Xinfa Pharmaceutical Co. Ltd
    • Hubei Guangji Pharmaceutical Co. Ltd
    • NB Group Co. Ltd
    • Hegno
    • Legend Industries
    • Hebei Shengxue dacheng Pharmaceutical Co. Ltd
    • Duchefa Biochemie
    • Harman Finichem Ltd

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Form
    • Market Snippet, By Source
    • Market Snippet, By Application
    • Market Snippet, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • PEST Analysis
    • PORTER's Five Forces Analysis
    • Market Opportunities
    • Regulatory Scenario
    • Key Developments
    • Industry Trend

4. Global Riboflavin Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overview
  • Factors Affecting the Global Riboflavin Market - COVID-19
  • Impact Analysis

5. Global Riboflavin Market, By Form, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025, 2028, and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Powder
    • Market Share Analysis, 2025, 2028, and 2032 (%)
    • Y-o-Y Growth Analysis, 2021- 2032
    • Segment Trends
  • Liquid
    • Market Share Analysis, 2025, 2028, and 2032 (%)
    • Y-o-Y Growth Analysis, 2021- 2032
    • Segment Trends
    • Segment Trends

6. Global Riboflavin Market, By Source, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025, 2028, and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Plant
    • Market Share Analysis, 2025, 2028, and 2032 (%)
    • Y-o-Y Growth Analysis, 2021- 2032
    • Segment Trends
  • Animal
    • Market Share Analysis, 2025, 2028, and 2032 (%)
    • Y-o-Y Growth Analysis, 2021- 2032
    • Segment Trends

7. Global Riboflavin Market, By Application, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025, 2028, and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Food and Beverages
    • Market Share Analysis, 2025, 2028, and 2032 (%)
    • Y-o-Y Growth Analysis, 2021- 2032
    • Segment Trends
  • Dietary Supplements
    • Market Share Analysis, 2025, 2028, and 2032 (%)
    • Y-o-Y Growth Analysis, 2021- 2032
    • Segment Trends
  • Pharmaceutical
    • Market Share Analysis, 2025, 2028, and 2032 (%)
    • Y-o-Y Growth Analysis, 2021- 2032
    • Segment Trends
  • Animal Feed
    • Market Share Analysis, 2025, 2028, and 2032 (%)
    • Y-o-Y Growth Analysis, 2021- 2032
    • Segment Trends
  • Personal Care
    • Market Share Analysis, 2025, 2028, and 2032 (%)
    • Y-o-Y Growth Analysis, 2021- 2032
    • Segment Trends
  • Others
    • Market Share Analysis, 2025, 2028, and 2032 (%)
    • Y-o-Y Growth Analysis, 2021- 2032
    • Segment Trends

8. Global Riboflavin Market, By Region, 2020-2032, (USD Mn)

  • Introduction
    • Market Share Analysis, By Region, 2025, 2028, and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2021 - 2032
  • North America
    • Market Share Analysis, By Country, 2025, 2028 and 2032 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2032
    • Market Size and Forecast, By Form, 2020- 2032, (USD Mn)
    • Market Size and Forecast, By Source, 2020- 2032, (USD Mn)
    • Market Size and Forecast, By Application, 2020- 2032, (USD Mn)
    • Market Size and Forecast, By Country, 2020- 2032, (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Market Share Analysis, By Country, 2025, 2028 and 2032 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2032
    • Market Size and Forecast, By Form, 2020- 2032, (USD Mn)
    • Market Size and Forecast, By Source, 2020- 2032, (USD Mn)
    • Market Size and Forecast, By Application, 2020- 2032, (USD Mn)
    • Market Size and Forecast, By Country, 2020- 2032, (USD Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Market Share Analysis, By Country, 2025, 2028 and 2032 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2032
    • Market Size and Forecast, By Form, 2020- 2032, (USD Mn)
    • Market Size and Forecast, By Source, 2020- 2032, (USD Mn)
    • Market Size and Forecast, By Application, 2020- 2032, (USD Mn)
    • Market Size and Forecast, By Country, 2020- 2032, (USD Mn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Market Share Analysis, By Country, 2025, 2028 and 2032 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2032
    • Market Size and Forecast, By Form, 2020- 2032, (USD Mn)
    • Market Size and Forecast, By Source, 2020- 2032, (USD Mn)
    • Market Size and Forecast, By Application, 2020- 2032, (USD Mn)
    • Market Size and Forecast, By Country, 2020- 2032, (USD Mn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Market Share Analysis, By Country, 2025, 2028 and 2032 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2032
    • Market Size and Forecast, By Form, 2020- 2032, (USD Mn)
    • Market Size and Forecast, By Source, 2020- 2032, (USD Mn)
    • Market Size and Forecast, By Application, 2020- 2032, (USD Mn)
    • Market Size and Forecast, By Country, 2020- 2032, (USD Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Market Share Analysis, By Country, 2025, 2028 and 2032 (%)
    • Y-o-Y Growth Analysis, For Country, 2021 - 2032
    • Market Size and Forecast, By Form, 2020- 2032, (USD Mn)
    • Market Size and Forecast, By Source, 2020- 2032, (USD Mn)
    • Market Size and Forecast, By Application, 2020- 2032, (USD Mn)
    • Market Size and Forecast, By Country/Region, 2020- 2032, (USD Mn)
      • South Africa
      • North Africa
      • Central Africa

9. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis (3x3 Matrix)
  • Company Profiles
    • BASF SE
      • Company Overview
      • Chair Type Portfolio
      • Recent Developments/Updates
    • Koninklijke DSM NV
      • Company Overview
      • Chair Type Portfolio
      • Recent Developments/Updates
    • Shanghai Acebright Pharmaceuticals Group Co. Ltd.
      • Company Overview
      • Chair Type Portfolio
      • Recent Developments/Updates
    • Xinfa Pharmaceutical Co. Ltd
      • Company Overview
      • Chair Type Portfolio
      • Recent Developments/Updates
    • Hubei Guangji Pharmaceutical Co. Ltd
      • Company Overview
      • Chair Type Portfolio
      • Recent Developments/Updates
    • NB Group Co. Ltd
      • Company Overview
      • Chair Type Portfolio
      • Recent Developments/Updates
    • Hegno
    • Legend Industries
    • Hebei Shengxue dacheng Pharmaceutical Co. Ltd
    • Duchefa Biochemie
    • Harman Finichem Ltd

10. Analyst Recommendation

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. Section

  • References
  • Research Methodology
  • About Us and Sales Contact